modafinil has been researched along with Attention Deficit and Disruptive Behavioral Disorders in 3 studies
Modafinil: A benzhydryl acetamide compound, central nervous system stimulant, and CYP3A4 inducing agent that is used in the treatment of NARCOLEPSY and SLEEP WAKE DISORDERS.
modafinil : A racemate comprising equimolar amounts of armodafinil and (S)-modafinil. A central nervous system stimulant, it is used for the treatment of sleeping disorders such as narcolepsy, obstructive sleep apnoea, and shift-work sleep disorder. The optical enantiomers of modafinil have similar pharmacological actions in animals.
2-[(diphenylmethyl)sulfinyl]acetamide : A sulfoxide that is dimethylsulfoxide in which two hydrogens attached to one of the methyl groups are replaced by phenyl groups, while one hydrogen attached to the other methyl group is replaced by a carbamoyl (aminocarbonyl) group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Narcolepsy is a neurological disorder affecting the regulation of sleep and wakefulness." | 1.35 | Narcolepsy--master of disguise: evidence-based recommendations for management. ( Mohsenin, V, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mohsenin, V | 1 |
| Brown, SR | 1 |
| Newcorn, JH | 1 |
| Ivanov, I | 1 |
3 other studies available for modafinil and Attention Deficit and Disruptive Behavioral Disorders
| Article | Year |
|---|---|
Narcolepsy--master of disguise: evidence-based recommendations for management.
Topics: Adjuvants, Anesthesia; Attention Deficit and Disruptive Behavior Disorders; Benzhydryl Compounds; Ca | 2009 |
Disease mongering and excessive daytime sleepiness.
Topics: Attention Deficit and Disruptive Behavior Disorders; Benzhydryl Compounds; Central Nervous System St | 2009 |
Psychopharmacologic treatment of attention-deficit/hyperactivity disorder and disruptive behavior disorders.
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Atomoxetine Hydrochloride; Attention Deficit an | 2007 |